Helsinki Business and Science Park (HBSP) provides a dynamic business environment with a diversified research and expert network and a Centre of Expertise within biotechnology, drug development and diagnostics, as well as food and environmental technology. Our objective is to improve the success opportunities of Finnish companies on the international market, and to improve domestic competitiveness.
17/06/2010
Oncos Therapeutics, a biotech company developing new cancer therapeutics based on the next generation oncolytic viruses, published today initial results from its Advanced Therapy Access Program in Cancer Research.
03/05/2010
Helsinki Business and Science Park would like to invite you to the Biotech Business Lounge – an event to meet today’s and tomorrow’s Finnish Life Science entrepreneurs in an informal setting.
29/04/2010
The representatives of the cities of Helsinki and Akron (Ohio) have agreed on a joint objective to offer establishing services to life science companies. To reach the goal, the cities will create a biotechnology bridge between Helsinki and Akron.